Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Rappl

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Cellular Biochemistry|April 12, 2003
Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link?Jörg Reichrath, Gunter Rappl
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation"Andreas A Hombach, Gunter Rappl, Hinrich Abken
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2019
Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30<sup>-</sup> TumorsAndreas A Hombach, Gunter Rappl, Hinrich Abken
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptorAndreas Hombach, Heike Köhler, Gunter Rappl, et al.
Human Gene Therapy|January 29, 2013
Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulationAndreas A Hombach, Markus Chmielewski, Gunter Rappl, et al.
Rejuvenation Research|September 23, 2008
Extensive amplification of human regulatory T cells alters their functional capacities and targets them to the peripheryGunter Rappl, Annette Schmidt, Cornelia Mauch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2Andreas A Hombach, David Kofler, Anja Hombach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2021
IL12 integrated into the CAR exodomain converts CD8<sup>+</sup> T cells to poly-functional NK-like cells with superior killing of antigen-loss tumorsAndreas Hombach, Markus Barden, Lisa Hannappel, et al.
The EMBO Journal|June 23, 2011
TCF/Lef1 activity controls establishment of diverse stem and progenitor cell compartments in mouse epidermisMonika Petersson, Heike Brylka, Andreas Kraus, et al.
Plos One|February 1, 2012
The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cellsGunter Rappl, Tobias Riet, Sabine Awerkiew, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry|April 12, 2003
Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link?Jörg Reichrath, Gunter Rappl
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation"Andreas A Hombach, Gunter Rappl, Hinrich Abken
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2019
Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30<sup>-</sup> TumorsAndreas A Hombach, Gunter Rappl, Hinrich Abken
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptorAndreas Hombach, Heike Köhler, Gunter Rappl, et al.
Human Gene Therapy|January 29, 2013
Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulationAndreas A Hombach, Markus Chmielewski, Gunter Rappl, et al.
Rejuvenation Research|September 23, 2008
Extensive amplification of human regulatory T cells alters their functional capacities and targets them to the peripheryGunter Rappl, Annette Schmidt, Cornelia Mauch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2Andreas A Hombach, David Kofler, Anja Hombach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2021
IL12 integrated into the CAR exodomain converts CD8<sup>+</sup> T cells to poly-functional NK-like cells with superior killing of antigen-loss tumorsAndreas Hombach, Markus Barden, Lisa Hannappel, et al.
The EMBO Journal|June 23, 2011
TCF/Lef1 activity controls establishment of diverse stem and progenitor cell compartments in mouse epidermisMonika Petersson, Heike Brylka, Andreas Kraus, et al.
Plos One|February 1, 2012
The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cellsGunter Rappl, Tobias Riet, Sabine Awerkiew, et al.
Pageof 3